BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28766045)

  • 1. PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.
    Mohanan S; Horibata S; Anguish LJ; Mukai C; Sams K; McElwee JL; McLean D; Yan A; Coonrod SA
    Cell Tissue Res; 2017 Nov; 370(2):275-283. PubMed ID: 28766045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.
    Pena JC; Rudin CM; Thompson CB
    Cancer Res; 1998 May; 58(10):2111-6. PubMed ID: 9605754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia.
    McElwee JL; Mohanan S; Horibata S; Sams KL; Anguish LJ; McLean D; Cvitaš I; Wakshlag JJ; Coonrod SA
    Cancer Res; 2014 Nov; 74(21):6306-17. PubMed ID: 25213324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
    Shibata MA; Ward JM; Green JE; Merlino G
    Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
    Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
    Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
    Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-melanoma skin cancer in mouse and man.
    Schwarz M; Münzel PA; Braeuning A
    Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
    Murphy JE; Morales RE; Scott J; Kupper TS
    J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.
    Torchia EC; Chen Y; Sheng H; Katayama H; Fitzpatrick J; Brinkley WR; Caulin C; Sen S; Roop DR
    Cancer Res; 2009 Sep; 69(18):7207-15. PubMed ID: 19738056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
    Winter M; Lodygin D; Verdoodt B; Hermeking H
    Oncotarget; 2016 Jul; 7(30):46862-46870. PubMed ID: 27409835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.